# CSF2RB

## Overview
The CSF2RB gene encodes the beta subunit of the colony stimulating factor 2 receptor, a critical component of the cytokine receptor family involved in immune and inflammatory responses. This receptor subunit is essential for the function of the receptor complex that binds cytokines such as GM-CSF, IL-3, and IL-5, which are pivotal in the regulation of growth, differentiation, and survival of hematopoietic cells. The CSF2RB protein itself is a transmembrane receptor that plays a significant role in signal transduction, facilitating communication from the extracellular environment to the cell's interior through various signaling pathways, including the JAK/STAT pathway. Mutations in this gene can lead to disorders such as pulmonary alveolar proteinosis and are associated with diseases like Crohn's disease, highlighting its importance in both health and disease (Chuang2016A; Suzuki2010Hereditary; Hetzel2017Function).

## Structure
The CSF2RB protein, also known as the colony stimulating factor 2 receptor beta subunit, is integral to the cytokine receptor family and plays a pivotal role in immune system regulation. The molecular structure of CSF2RB is characterized by several key domains that are essential for its function. The extracellular domain of CSF2RB is responsible for ligand binding, which is crucial for the activation of the receptor by cytokines such as GM-CSF, IL-3, and IL-5. This domain facilitates the initial interaction with these cytokines, leading to subsequent signaling events.

Additionally, CSF2RB features a transmembrane domain that anchors the protein in the cell membrane, providing a critical link between the extracellular and intracellular environments. The cytoplasmic domain of CSF2RB is involved in signal transduction, transmitting signals from the extracellular cytokine-receptor interaction to intracellular signaling pathways that influence various immune responses.

Post-translational modifications and the presence of splice variant isoforms of CSF2RB can significantly influence its function and interactions within the cytokine receptor complex. These modifications and variants may alter the protein's stability, localization, or interaction with other signaling molecules, thereby modulating its role in immune regulation.

## Function
The CSF2RB gene encodes the beta subunit of the receptor for cytokines such as GM-CSF (granulocyte-macrophage colony-stimulating factor), IL-3, and IL-5, which are essential for the function of various immune cells. This receptor subunit plays a pivotal role in the signaling pathways that regulate the growth, differentiation, and survival of hematopoetic stem cells into myeloid cells, including monocytes, macrophages, and granulocytes (Chuang2016A).

CSF2RB is part of a receptor complex that, upon binding with GM-CSF, activates several intracellular signaling pathways. One of the key pathways involves the activation of JAK2/STAT5 signaling, which is crucial for the proliferation and differentiation of myeloid cells. The phosphorylation of STAT5, facilitated by CSF2RB, is a critical step in mediating cellular responses to GM-CSF (Chuang2016A; Hetzel2017Function).

In addition to its role in hematopoiesis, CSF2RB is also involved in maintaining pulmonary health by regulating the function of alveolar macrophages, which are crucial for clearing surfactants and other lipoproteins from the alveoli (Mucci2018iPSC-Derived; Suzuki2010Hereditary). Mutations in CSF2RB can lead to conditions such as pulmonary alveolar proteinosis, highlighting the gene's essential role in respiratory function (Suzuki2010Hereditary).

## Clinical Significance
Mutations in the CSF2RB gene, which encodes the beta chain of the GM-CSF receptor, are linked to several clinical conditions due to their critical role in immune system functioning. Notably, a frameshift mutation in CSF2RB is prevalent among Ashkenazi Jews and has been associated with an increased risk of Crohn's disease. This mutation leads to reduced signaling via GM-CSF, impacting monocyte function and contributing to the pathogenesis of the disease by impairing intestinal tolerance and immune responses (Chuang2016A).

Additionally, CSF2RB mutations are implicated in pulmonary alveolar proteinosis (PAP), a condition characterized by the accumulation of surfactant in the alveoli, leading to respiratory insufficiency. This is due to mutations that disrupt GM-CSF signaling, essential for the maturation and function of alveolar macrophages. A specific case involved a homozygous point mutation (c.812C.T, resulting in S271L) in a young patient, which impaired the GM-CSF receptor function and signaling (Suzuki2010Hereditary).

These examples highlight the significant impact of CSF2RB mutations on immune function and disease, underscoring the gene's clinical relevance in both gastrointestinal and respiratory conditions.

## Interactions
The CSF2RB protein, also known as the colony stimulating factor 2 receptor beta subunit, is involved in several critical protein-protein interactions that are essential for its function in immune signaling pathways. CSF2RB interacts with JAK2, a kinase that is associated with the cytoplasmic domain of CSF2RB. This interaction is crucial for the dimerization and transphosphorylation of JAK2 within the dodecamer complex, a process that enhances the signaling capabilities of the receptor, particularly in response to GM-CSF stimulation (Chuang2016A). 

Additionally, CSF2RB is part of a complex that includes specific tyrosine residues such as Tyr577, Tyr612, Tyr695, and Tyr750. These residues are vital for recruiting and activating downstream signaling molecules like MAP kinase and PI3 kinase, as well as mediating the activation of STAT5, a key transcription factor in immune response regulation (Chuang2016A).

Furthermore, CSF2RB has been shown to interact with long non-coding RNAs (lncRNAs) such as Exo1-4 and RMRP in studies involving exosomes. These interactions suggest a role in cellular metabolism and other cellular functions, indicating that CSF2RB may have broader implications in cell signaling beyond its established immune functions (Hewson2016Extracellular).


## References


[1. (Hewson2016Extracellular) Chris Hewson, David Capraro, Jon Burdach, Noel Whitaker, and Kevin V. Morris. Extracellular vesicle associated long non-coding rnas functionally enhance cell viability. Non-coding RNA Research, 1(1):3â11, October 2016. URL: http://dx.doi.org/10.1016/j.ncrna.2016.06.001, doi:10.1016/j.ncrna.2016.06.001. (94 citations) 10.1016/j.ncrna.2016.06.001](https://doi.org/10.1016/j.ncrna.2016.06.001)

[2. (Mucci2018iPSC-Derived) Adele Mucci, Elena Lopez-Rodriguez, Miriam Hetzel, Serena Liu, Takuji Suzuki, Christine Happle, Mania Ackermann, Henning Kempf, Roman Hillje, Jessica Kunkiel, Ewa Janosz, Sebastian Brennig, Silke Glage, Jens P. Bankstahl, Sabine Dettmer, Thomas Rodt, Gudrun Gohring, Bruce Trapnell, Gesine Hansen, Cole Trapnell, Lars Knudsen, Nico Lachmann, and Thomas Moritz. Ipsc-derived macrophages effectively treat pulmonary alveolar proteinosis in csf2rb-deficient mice. Stem Cell Reports, 11(3):696â710, September 2018. URL: http://dx.doi.org/10.1016/j.stemcr.2018.07.006, doi:10.1016/j.stemcr.2018.07.006. (50 citations) 10.1016/j.stemcr.2018.07.006](https://doi.org/10.1016/j.stemcr.2018.07.006)

[3. (Suzuki2010Hereditary) T. Suzuki, B. Maranda, T. Sakagami, P. Catellier, C.-Y. Couture, B. C. Carey, C. Chalk, and B. C. Trapnell. Hereditary pulmonary alveolar proteinosis caused by recessive csf2rb mutations. European Respiratory Journal, 37(1):201â204, December 2010. URL: http://dx.doi.org/10.1183/09031936.00090610, doi:10.1183/09031936.00090610. (139 citations) 10.1183/09031936.00090610](https://doi.org/10.1183/09031936.00090610)

[4. (Chuang2016A) Ling-Shiang Chuang, Nicole Villaverde, Ken Y. Hui, Arthur Mortha, Adeeb Rahman, Adam P. Levine, Talin Haritunians, Sok Meng Evelyn Ng, Wei Zhang, Nai-Yun Hsu, Jody-Ann Facey, Tramy Luong, Heriberto Fernandez-Hernandez, Dalin Li, Manuel Rivas, Elena R. Schiff, Alexander Gusev, L. Phillip Schumm, Beatrice M. Bowen, Yashoda Sharma, Kaida Ning, Romain Remark, Sacha Gnjatic, Peter Legnani, James George, Bruce E. Sands, Joanne M. Stempak, Lisa W. Datta, Seth Lipka, Seymour Katz, Adam S. Cheifetz, Nir Barzilai, Nikolas Pontikos, Clara Abraham, Marla J. Dubinsky, Stephan Targan, Kent Taylor, Jerome I. Rotter, Ellen J. Scherl, Robert J. Desnick, Maria T. Abreu, Hongyu Zhao, Gil Atzmon, Itsik Peâer, Subra Kugathasan, Hakon Hakonarson, Jacob L. McCauley, Todd Lencz, Ariel Darvasi, Vincent Plagnol, Mark S. Silverberg, Aleixo M. Muise, Steven R. Brant, Mark J. Daly, Anthony W. Segal, Richard H. Duerr, Miriam Merad, Dermot P.B. McGovern, Inga Peter, and Judy H. Cho. A frameshift in csf2rb predominant among ashkenazi jews increases risk for crohnâs disease and reduces monocyte signaling via gm-csf. Gastroenterology, 151(4):710-723.e2, October 2016. URL: http://dx.doi.org/10.1053/j.gastro.2016.06.045, doi:10.1053/j.gastro.2016.06.045. (56 citations) 10.1053/j.gastro.2016.06.045](https://doi.org/10.1053/j.gastro.2016.06.045)

[5. (Hetzel2017Function) Miriam Hetzel, Takuji Suzuki, Anna Rafiei Hashtchin, Paritha Arumugam, Brenna Carey, Marc Schwabbauer, Alexandra Kuhn, Johann Meyer, Axel Schambach, Johannes Van Der Loo, Thomas Moritz, Bruce C. Trapnell, and Nico Lachmann. Function and safety of lentivirus-mediated gene transfer forcsf2ra-deficiency. Human Gene Therapy Methods, 28(6):318â329, December 2017. URL: http://dx.doi.org/10.1089/hgtb.2017.092, doi:10.1089/hgtb.2017.092. (20 citations) 10.1089/hgtb.2017.092](https://doi.org/10.1089/hgtb.2017.092)